Gregory S. Bailey

333 W Wacker Drive, Chicago, IL 60606

Federal judge will allow consumer fraud claim to continue vs Pfizer over Robitussin labeling

By Scott Holland | Thursday, Jul 18, 2019 @ 5:43pm

A federal judge has again rejected pharmaceutical maker Pfizer’s request to end a potential consumer fraud class action over the labeling of its Robitussin Maximum Strength cough and cold medicine.
Judge: Difference between 'mass action,' 'class action' means Pfizer can't flush Robitussin suit

By Scott Holland | Friday, Aug 10, 2018 @ 1:08pm

A federal judge has rejected Pfizer’s attempt to scuttle a class action accusing the drugmaker of misleading consumers over the actual strength of its maximum strength Robitussin cough syrup, saying a U.S. Supreme Court decision doesn’t necessarily mean the company shouldn’t have to face a nationwide class action in Chicago federal court.